How to shorten the market entry innovation in a highly regulated market. The case of Early access programs in the pharmaceutical industry

[EN] Government regulation impacts deeply on the innovation process. Regulatory frameworks influence firms' innovativeness. This study aims to provide an exploratory investigation of Early Access programs as a tool to shorten the time to place innovation in highly regulated markets. Thus, our r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schiavone, Francesco, Bastone, Anna, Carli, Maria Rosaria, Juárez Varón, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[EN] Government regulation impacts deeply on the innovation process. Regulatory frameworks influence firms' innovativeness. This study aims to provide an exploratory investigation of Early Access programs as a tool to shorten the time to place innovation in highly regulated markets. Thus, our research question is: How do institutional actors push the entry of innovation in highly regulated markets? To address the research question, a qualitative analysis was conducted using the multiple case study method among different countries. The analysis practised an inductive approach. The results provide an inductive conceptual framework to identify different configurations of Early Access programs based on three characterizing dimensions: (1) authorities involved, (2) eligibility criteria and (3) applicant. This study provides implications for both theory and practice. Future research will be needed to investigate the emerging aspects further and make the model generalisable. Schiavone, F.; Bastone, A.; Carli, MR.; Juárez Varón, D. (2023). How to shorten the market entry innovation in a highly regulated market. The case of Early access programs in the pharmaceutical industry. International Entrepreneurship and Management Journal. 1-21. https://doi.org/10.1007/s11365-023-00893-y Adams, R., Bessant, J., & Phelps, R. (2006). Innovation management measurement: A review. International Journal of Management Reviews, 8(1), 21–47. https://doi.org/10.1111/j.1468-2370.2006.00119.x Aday, S., & Aday, M. S. (2020). Impact of COVID-19 on the food supply chain. Food Quality and Safety, 4(4), 167–180. https://doi.org/10.1093/fqsafe/fyaa024 Aldieri, L., Bruno, B., Senatore, L., & Vinci, C. P. (2020). The future of pharmaceuticals industry within the triad: The role of knowledge spillovers in the innovation process. Futures, 122, 102600. https://doi.org/10.1016/j.futures.2020.102600 Amable, B., Ledezma, I., & Robin, S. (2016). Product market regulation, innovation, and productivity. Research Policy, 45(10), 2087–2104. https://doi.org/10.1016/j.respol.2016.08.003 Apolone, G., Ardizzoni, A., Buzzetti, G., Clerico, M. A., Conte, P., de Braud, F., ... & Scroccaro, G. (2019). Early access in oncology: why is it needed? Global & Regional Health Technology Assessment, 2019, 2284240319857072. https://doi.org/10.1177/2284240319857072 Bansal, P., Smith, W. K., & Vaara, E. (2018). New ways of seeing through qualitative research. Academy of Management Journal, 61(4), 1189–1195. https://doi.org